S. KESKİN Et Al. , "The predictive role of midtreatment changes in survivin GSTP1 and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer," ASCO Annual Meeting , Chicago, Illinois, United States Of America, 2011
KESKİN, S. Et Al. 2011. The predictive role of midtreatment changes in survivin GSTP1 and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. ASCO Annual Meeting , (Chicago, Illinois, United States Of America).
KESKİN, S., ERALP, Y., AKIŞIK, E. Z., AKIŞIK, E. E., İĞCİ, A., MÜSLÜMANOĞLU, M. E., ... YILMAZ, S.(2011). The predictive role of midtreatment changes in survivin GSTP1 and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer . ASCO Annual Meeting, Chicago, Illinois, United States Of America
KESKİN, SERKAN Et Al. "The predictive role of midtreatment changes in survivin GSTP1 and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer," ASCO Annual Meeting, Chicago, Illinois, United States Of America, 2011
KESKİN, SERKAN Et Al. "The predictive role of midtreatment changes in survivin GSTP1 and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer." ASCO Annual Meeting , Chicago, Illinois, United States Of America, 2011
KESKİN, S. Et Al. (2011) . "The predictive role of midtreatment changes in survivin GSTP1 and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer." ASCO Annual Meeting , Chicago, Illinois, United States Of America.
@conferencepaper{conferencepaper, author={SERKAN KESKİN Et Al. }, title={The predictive role of midtreatment changes in survivin GSTP1 and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer}, congress name={ASCO Annual Meeting}, city={Chicago, Illinois}, country={United States Of America}, year={2011}}